Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Unmet Medical Needs, Regulatory Barriers Addressed In Public Comments

This article was originally published in The Gray Sheet

Executive Summary

Device makers list drug-therapy monitoring tests, venous disease and diabetes treatments, and products targeting children and rare diseases among the top unmet public health priorities for FDA and other government agencies
Advertisement

Related Content

FDA Withdraws Pediatric Data-Submission Rule, But Aims To Regroup Shortly
FDA Brainstorms New Regulatory Models To Address Unmet Health Needs
FDA Brainstorms New Regulatory Models To Address Unmet Health Needs
FDA And CMS Agree To Share Data Routinely In Step Toward Parallel Reviews
CDRH Pre-Market Reform Proposals Expected Within Weeks

Topics

Advertisement
UsernamePublicRestriction

Register

MT029211

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel